drug

NY Attorney General confirms real-life conspiracy among drug companies

Friday, February 21, 2014 by: J. D. Heyes
Tags: drug companies, real-life conspiracy, NY Attorney General

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
NJ cops bust teenagers shoveling snow without a permit
Chemotherapy kills cancer patients faster than no treatment at all
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
The 21 curious questions we're never allowed to ask about vaccines
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Delicious
(NaturalNews) The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully.

Both companies agreed to pay a small fine (by comparison) of $150,000 to New York State and to cease making similar agreements in the future as part of the settlement, Reuters reported. Neither company admitted or denied the allegations, but the settlement absolves them of having to do so.

By settling, the companies have ended an investigation that was being conducted by the state into an agreement that was signed by both in 2010 to sell a generic version of Pfizer, Inc.'s cholesterol-lowering drug Lipitor in the U.S., while not horning in on the exclusivity rights of other generic drugs sold by the pharmaceutical companies. Per Reuters:

The agreement was drawn up as a contingency plan to allow Israel's Teva to sell the generic Lipitor, or atorvastatin calcium, in case Ranbaxy's version was not approved by the U.S. Food and Drug Administration before Lipitor lost its patent protection on November 30, 2011.

While India's Ranbaxy, majority-owned by Japan's Daiichi Sankyo Co Ltd, eventually got FDA approval in time, the agreement remained in place and could have been used to protect other drugs made by the two companies.


'Pay-for-delay'

"Agreements between drug manufacturers to protect each other's market positions violate fundamental principles of antitrust law, and can lead to higher drug prices," Attorney General Eric Schneiderman said in a statement.

While the agreement related only to the sale of the one drug, it included a "no-challenge" clause, which allowed both companies to shield from competition, as well as legal and regulatory challenges, scores of other medications, according to the NY attorney general's office, which added, however, that no anti-competitive effects due to the agreement had been identified during the investigation.

Schneiderman says the entire ordeal represents the application of a recent legal precedent that arose from challenges of "pay-for-delay" agreements that were established between makers of brand-name and generic drugs.

Those deals, where a brand-name Pharma company pays a generic rival not to sell their versions of a drug at a much-reduced price, have caught the attention of regulators in countries all over the world, because such agreements raise patient-care costs as well as the public sector's costs to cover healthcare treatments.

Criminal enterprise

"Ranbaxy... continues to believe that the agreement was pro-competitive and an important part of making the product readily available to patients and the U.S. healthcare system in a timely fashion," a Ranbaxy spokesman said in an email to Reuters, but the other company involved, Teva, would not comment.

"The settlement is positive for (Ranbaxy). The settlement amount will not significantly impact the company," said Sarabjit Kour Nangra, an analyst at Angel Broking, as quoted by the newswire service.

Ranbaxy was banned from exporting drugs to the U.S. after failing to abide by U.S. Food and Drug Administration manufacturing standards.

Natural News has reported on illegal activity committed by Big Pharma companies often in the past. As our editor, Mike Adams, the Health Ranger, has documented, anyone who has labeled the industry as little more than a criminal enterprise has been vindicated time and again. In 2012, Mike wrote:

Drug and vaccine manufacturer Merck was caught red-handed by two of its own scientists faking vaccine efficacy data by spiking blood samples with animal antibodies. GlaxoSmithKline has just been fined a whopping $3 billion for bribing doctors, lying to the FDA, hiding clinical trial data and fraudulent marketing. Pfizer, meanwhile has been sued by the nation's pharmacy retailers for what is alleged as an "overarching anticompetitive scheme" to keep generic cholesterol drugs off the market and thereby boost its own profits.

This latest settlement with authorities in New York further documents the previous pattern of criminality.

Sources:

http://www.reuters.com

http://www.naturalnews.com

http://www.naturalnews.com

Explore more on Drug companies by searching on GoodGopher.com, the search engine for truth seekers.
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.